New combo therapy aims to help spinal cord injury patients walk again

NCT ID NCT06853015

Recruiting now Disease control Sponsor: Shirley Ryan AbilityLab Source: ClinicalTrials.gov ↗

First seen Jun 08, 2026 · Last updated Jun 12, 2026 · Updated 1 time

Summary

This study tests whether a drug called 4-AP, taken twice daily, can boost leg function when combined with special nerve stimulation and limb training in people with spinal cord injury. The trial involves 27 adults who are at least 6 months post-injury. The goal is to improve muscle strength and walking ability, not to cure the injury.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shirley Ryan Abilitylab
RECRUITING

Chicago, Illinois, 60611, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SCI - SPINAL CORD INJURY

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

SPINAL CORD INJURY